Fenwal Inc Amicus Exchange Kit Therapeutics - Product Usage: intended for use in the collection of blood components and mononuclear cells. Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Amicus Exchange Kit Therapeutics - Product Usage: intended for use in the collection of blood components and mononuclear cells.
Brand
Fenwal Inc
Lot Codes / Batch Numbers
Product Code X6R2349, UDI: 04086000101950, Batch Numbers FA20E25150 (Exp. 05/31/2022) and FA20I22142 (Exp. 09/30/2022)
Products Sold
Product Code X6R2349; UDI: 04086000101950; Batch Numbers FA20E25150 (Exp. 05/31/2022) and FA20I22142 (Exp. 09/30/2022)
Fenwal Inc is recalling Amicus Exchange Kit Therapeutics - Product Usage: intended for use in the collection of blood compon due to Some lots of Amicus MNC Apheresis and Amicus Exchange kits have leaking centrifuge packs during a procedure on the Amicus Separator using therapeutic . Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Some lots of Amicus MNC Apheresis and Amicus Exchange kits have leaking centrifuge packs during a procedure on the Amicus Separator using therapeutic protocols only. The defect is a blood leak at the boot, elbow, or in the channel on the separation chamber of the centrifuge pack.
Recommended Action
Per FDA guidance
A Recall notification letter titled, "URGENT - Medical Device Recall Amicus MNC Apheresis/Exchange Disposable Kits" and form titled, Amicus Therapeutic Kits Customer Reply Form were sent to consignees on 02/25/2021 via Fed Ex Overnight Express. The consignee requested their customers to: 1) Discontinue use of the affected products immediately by checking their inventory and quarantining all affected product at their facility. They were also informed to contact Fresenius Kabi Customer Service at 800-333-6925, Prompt 1 for replacement kits to ensure additional procedures can continue. 2) Inform potential users of the product in their organization of this notification. 3) Based on the options listed below, complete the attached response form and return via the fax number, email address, or the enclosed Fed Ex envelope and return address. Option A: If there is no remaining inventory of the affected product complete the response form and return it to Fresenius Kabi. Option B: If the customer has affected product in inventory and wishes to return it: Contact Fresenius Kabi Customer Service at 800-333-6925, Prompt 1 and request to return the affected product. They will assist the customer with placing a replacement order at that time. Option C: If the customer has a small number of kits in inventory and are willing to destroy the product on Fresenius Kabis behalf: Contact Fresenius Kabi Customer Service at 800-333-6925, Prompt 1 to identify if the customer has product to be destroyed and require replacement. They will provide a certificate of destruction for completion. Once completed, the certificate should be returned to Fresenius Kabi and replacements will be sent. Customers may be in a position that no alternate Device is available and therefore choose to continue with the use of the affected Amicus MNC Apheresis kits or Amicus Exchange kits (Therapeutics kits). For such cases, the following actions should be put in place until replacement products a
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026